Safety and Therapeutic Effect of Insulin Detemir in Taiwanese Patients With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets With OAD With/Without Once-daily NPH Insulin Treatment

NCT00521690 Phase 4 COMPLETED

The trial is conducted in Asia. The aim of the trial is to evaluate the effect of insulin detemir on blood glucose control in Taiwanese patients with type 2 diabetes failing on OAD with/without once-daily NPH Insulin treatment.

Details

Lead sponsor	Novo Nordisk A/S
Phase	Phase 4
Status	COMPLETED
Enrolment	25
Start date	2006-12
Completion	2007-08

Conditions

• Diabetes
• Diabetes Mellitus, Type 2

Interventions

• insulin detemir

Primary outcomes

• Incidence of serious adverse events, including major hypoglycaemic events — during 16 weeks of insulin detemir therapy

Countries

Taiwan